Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China
· Delayed Price · Currency is CNY 43.66
-0.82 (-1.84%)
May 14, 2025, 2:45 PM CST
SHE:300957 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 5,559 | 5,707 | 5,707 | 4,998 | 4,008 | 2,621 | Upgrade
|
| Other Revenue | 29.11 | 29.11 | 20.55 | 16.12 | 14.63 | 15.91 | Upgrade
|
| Revenue | 5,588 | 5,736 | 5,727 | 5,014 | 4,022 | 2,636 | Upgrade
|
| Revenue Growth (YoY) | -6.26% | 0.15% | 14.23% | 24.65% | 52.57% | 35.64% | Upgrade
|
| Cost of Revenue | 1,473 | 1,565 | 1,462 | 1,262 | 977.08 | 635.17 | Upgrade
|
| Gross Profit | 4,115 | 4,170 | 4,266 | 3,752 | 3,045 | 2,001 | Upgrade
|
| Selling, General & Admin | 3,440 | 3,379 | 3,023 | 2,391 | 1,926 | 1,276 | Upgrade
|
| Research & Development | 320.44 | 295.17 | 298.82 | 254.7 | 113.22 | 63.44 | Upgrade
|
| Other Operating Expenses | 68.95 | 63.06 | 47.45 | 54.71 | 52.12 | 10.77 | Upgrade
|
| Operating Expenses | 3,841 | 3,750 | 3,382 | 2,700 | 2,097 | 1,355 | Upgrade
|
| Operating Income | 273.28 | 420.76 | 883.6 | 1,052 | 948.45 | 645.86 | Upgrade
|
| Interest Expense | -18.71 | -17.59 | -4.97 | -4.75 | -4.19 | -1.33 | Upgrade
|
| Interest & Investment Income | 73.57 | 82.5 | 92.91 | 100.88 | 33.62 | 5.7 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.23 | -1.23 | -0.72 | 0.03 | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 3.69 | -1.13 | -215.84 | -1.72 | -0.53 | -2.21 | Upgrade
|
| EBT Excluding Unusual Items | 330.6 | 483.32 | 754.97 | 1,147 | 977.35 | 648.01 | Upgrade
|
| Impairment of Goodwill | -90.69 | -90.69 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 169.2 | 177.55 | -17.24 | -5.52 | 10.8 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -6.77 | -4.15 | 0.69 | -0.03 | 0.52 | -0.17 | Upgrade
|
| Asset Writedown | -12.68 | -25 | - | - | - | - | Upgrade
|
| Other Unusual Items | 66.48 | 67.37 | 130.39 | 72.75 | 29.21 | - | Upgrade
|
| Pretax Income | 456.14 | 608.4 | 868.82 | 1,214 | 1,018 | 647.84 | Upgrade
|
| Income Tax Expense | 102.57 | 113.61 | 109.61 | 163.33 | 153.81 | 104.08 | Upgrade
|
| Earnings From Continuing Operations | 353.57 | 494.79 | 759.21 | 1,051 | 864.06 | 543.75 | Upgrade
|
| Minority Interest in Earnings | 0.98 | 8.26 | -2.42 | 0.8 | -1.14 | -0.25 | Upgrade
|
| Net Income | 354.55 | 503.05 | 756.8 | 1,051 | 862.92 | 543.51 | Upgrade
|
| Net Income to Common | 354.55 | 503.05 | 756.8 | 1,051 | 862.92 | 543.51 | Upgrade
|
| Net Income Growth | -54.27% | -33.53% | -28.02% | 21.83% | 58.77% | 31.94% | Upgrade
|
| Shares Outstanding (Basic) | 415 | 419 | 423 | 424 | 407 | 360 | Upgrade
|
| Shares Outstanding (Diluted) | 415 | 419 | 423 | 424 | 407 | 360 | Upgrade
|
| Shares Change (YoY) | -1.42% | -0.85% | -0.27% | 4.15% | 13.09% | -0.39% | Upgrade
|
| EPS (Basic) | 0.85 | 1.20 | 1.79 | 2.48 | 2.12 | 1.51 | Upgrade
|
| EPS (Diluted) | 0.85 | 1.20 | 1.79 | 2.48 | 2.12 | 1.51 | Upgrade
|
| EPS Growth | -53.62% | -32.96% | -27.82% | 16.98% | 40.40% | 32.46% | Upgrade
|
| Free Cash Flow | 106.92 | 316.48 | 336.16 | 416.02 | 882.04 | 341.57 | Upgrade
|
| Free Cash Flow Per Share | 0.26 | 0.76 | 0.80 | 0.98 | 2.17 | 0.95 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.600 | 0.800 | 0.600 | 0.450 | Upgrade
|
| Dividend Growth | -0.08% | -0.08% | -24.94% | 33.33% | 33.33% | 60.71% | Upgrade
|
| Gross Margin | 73.64% | 72.71% | 74.48% | 74.83% | 75.71% | 75.91% | Upgrade
|
| Operating Margin | 4.89% | 7.34% | 15.43% | 20.99% | 23.58% | 24.50% | Upgrade
|
| Profit Margin | 6.35% | 8.77% | 13.21% | 20.97% | 21.45% | 20.61% | Upgrade
|
| Free Cash Flow Margin | 1.91% | 5.52% | 5.87% | 8.30% | 21.93% | 12.96% | Upgrade
|
| EBITDA | 374.74 | 516.08 | 954.32 | 1,110 | 968.11 | 659.61 | Upgrade
|
| EBITDA Margin | 6.71% | 9.00% | 16.66% | 22.15% | 24.07% | 25.02% | Upgrade
|
| D&A For EBITDA | 101.47 | 95.32 | 70.72 | 58.23 | 19.66 | 13.74 | Upgrade
|
| EBIT | 273.28 | 420.76 | 883.6 | 1,052 | 948.45 | 645.86 | Upgrade
|
| EBIT Margin | 4.89% | 7.34% | 15.43% | 20.99% | 23.58% | 24.50% | Upgrade
|
| Effective Tax Rate | 22.49% | 18.67% | 12.62% | 13.46% | 15.11% | 16.07% | Upgrade
|
| Revenue as Reported | 5,588 | 5,736 | 5,522 | 5,014 | 4,022 | 2,636 | Upgrade
|
| Advertising Expenses | - | 2,046 | 1,922 | 1,534 | 1,249 | 811.84 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.